Drug Database
Back to search

Belgium· BE-AMP-SAM662556-00

Celldemic

A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing influenza virus a/turkey/turkey/1/2005 (h5n1) nibrg-23 strain, ha surface antigen, registered in Belgium by Seqirus Netherlands. The same ATC class is registered in 11 of our 19 countries.

ATC J07BB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCelldemicATCJ07BB02REGISTER NO.BE-AMP-SAM662556-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about influenza virus a/turkey/turkey/1/2005 (h5n1) nibrg-23 strain, ha surface antigenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search influenza, inaktiviert, spalt/split virus oder oberflächen-antigen products by name

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Influenza Virus A/Turkey/Turkey/1/2005 (H5N1) NIBRG-23 Strain, HA Surface Antigen
Manufacturer
Seqirus Netherlands
Country
Belgium (BE)
ATC code
J07BB02
ATC class
Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BB02

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen, as other registers publish it.

All influenza, inaktiviert, spalt/split virus oder oberflächen-antigen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db08ebe8-7ea1-4ba8-81d3-d3c69d8c9353
GET /v1/drugs/db08ebe8-7ea1-4ba8-81d3-d3c69d8c9353?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Celldemic",
  "name_fr": "Celldemic",
  "name_nl": "Celldemic",
  "amp_code": "SAM662556-00",
  "strengths": [
    "7.5000",
    "7.5000",
    "1.1750"
  ],
  "pack_count": 1,
  "substances": [
    "Influenza Virus A/Turkey/Turkey/1/2005 (H5N1) NIBRG-23 Strain, HA Surface Antigen",
    "Disodium Hydrogen Orthophosphate",
    "Potassium Chloride",
    "Potassium Dihydrogen Phosphate",
    "Sodium Chloride",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Influenza, Inactivated, Split Virus Or Surface Antigen",
  "authorisation_numbers": [
    "EU/1/24/1806/001"
  ]
}
API referenceMCP serverPlans

See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console